Option chain shows key data for Guardion Health Sciences's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Guardion Health Sciences.

Guardion Health Sciences (OTC:GHSI) Stock, Option Chain

Guardion Health Sciences

Guardion Health Sciences Inc clinical nutrition company that develops and distributes clinically supported dietary supplements and medical foods. It offers a portfolio of science-based, clinically supported products designed to support consumers, healthcare professionals and providers, and their patients by supporting bone health, eye health, cardiovascular health, and brain health through nutrients such as Calcium, Vitamin D, Vitamin K, Carotenoids, and Omega-3s.

eye-5248678

News

GHSI

Guardion Health Sciences shares are trading lower by 38% during Tuesday&#39;s session. The company announced it adopted a plan of dissolution and liquidation.

Why Guardion Health Sciences (GHSI) Stock Is Getting Hammered

Titoli a dividendo scelti dai migliori analisti di Wall Street

Earnings

Equities

Eurozone

Commodities

Markets

Trading Ideas

ALAR

Citigourp Global Markets 2% Protected Notes Linked To The Djia

Dow Jumps 100 Points; PDD Posts Weak Revenue

movers image

Pre-Market Outlook

Movers

AIEV

BENF

CLOV

GLMD

KDLY

MOBX

NTBL

NXPL

QMCO

REVB

ROMA

SNOW

STAF

STEC

URBN

VRAX

WOLF

Why Wolfspeed Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket

Guardion Health Sciences Inc

AREN

Arena Group Says It Delivered First-Ever Quarter Of Positive Net Income

<p>GameSquare Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GAME#NASDAQ">GAME</a>) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.16) by 6.25 percent.  The company reported quarterly sales of $26.413 million which missed the analyst consensus estimate of $26.500 million by 0.33 percent.  This is a 64.62 percent increase over sales of $16.045 million the same period last year.</p>


Earnings Beats

Earnings Misses

GAME

GameSquare Holdings Q3 2024 Adj. EPS $(0.15) Beats $(0.16) Estimate, Sales $26.413M Miss $26.500M Estimate

Appaloosa LP 13F Shows Exited Position In United Parcel Service, Previously Holding 605,000 Shares; Exited Position In Boeing, Previously Holding 210,000 Shares; Exited Position In Macy's, Previously Holding 1,265,000 Shares

PLTR

Palantir Announces Transfer Of Stock Exchange Listing To Nasdaq On Nov. 26

<p>iPower (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPW#NASDAQ">IPW</a>) reported quarterly losses of $(0.06) per share which missed the analyst consensus estimate of $0.02 by 400 percent. This is a 50 percent decrease over losses of $(0.04) per share from the same period last year.  The company reported quarterly sales of $19.01 million which missed the analyst consensus estimate of $20.90 million by 9.05 percent.  This is a 28.29 percent decrease over sales of $26.51 million the same period last year.</p>


iPower Q1 EPS $(0.06) Misses $0.02 Estimate, Sales $19.01M Miss $20.90M Estimate

Management

OMGA

Omega Therapeutics Appoints Kaan Certel, Ph.D As President As CEO

AMZN

BABA

MSFT

ORCL

Appaloosa LP 13F Shows Decreased Stake In Alibaba Group By 5% From 10,500,000 To 10,000,000 Shares; Decreased Stake In Amazon By 8% From 3,475,000 To 3,200,000 Shares;  Decreased Stake In Microsoft By 18% From 1,181,356 To 970,000 Shares; Decreased Stake In Meta Platforms By 33% From 935,000 To 625,000 Shares; Decreased Stake In Oracle By 21% From 2,000,000 To 1,573,394 Shares; Decreased Stake In Advanced Micro Devices By 17% From 1,370,000 To 1,135,000 Shares

Arena Group Holdings Q3 EPS From Continuing Operations $0.13 Up From $(0.37) YoY, Sales $33.56M Down From $36.99M YoY

WIIM

Arena Group shares are trading higher after it announced its first ever profitable quarter.

APLD

NVDA

13F Shows Nvidia Corp Added Stake In Applied Digital Corp With 7,716,050 Shares

IXHL

Incannex Healthcare Q1 EPS $(0.29) Down From $(0.08)

<p>IZEA Worldwide (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IZEA#NASDAQ">IZEA</a>) reported quarterly losses of $(0.52) per share which missed the analyst consensus estimate of $(0.11) by 372.73 percent.  The company reported quarterly sales of $8.832 million which missed the analyst consensus estimate of $10.750 million by 17.84 percent.  This is a 11.87 percent increase over sales of $7.895 million the same period last year.</p>


IZEA

IZEA Worldwide Q3 2024 GAAP EPS $(0.52) Misses $(0.11) Estimate, Sales $8.832M Miss $10.750M Estimate

BEKE

LYFT

Appaloosa LP 13F Shows Increased Stake In PDD Holdings By 173% From 1,940,000 To 5,301,132 Shares; Increased Stake In JD.com Inc By 69% From 4,310,600 To 7,300,000 Shares;  Increased Stake In Lyft By 98% From 7,961,257 To 15,750,000 Shares; Increased Stake In KE Holdings By 4% From 2,085,000 To 2,175,000 Shares

<p>AST SpaceMobile (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTS#NASDAQ">ASTS</a>) reported quarterly losses of $(1.10) per share which missed the analyst consensus estimate of $(0.20) by 450 percent.  The company reported quarterly sales of $1.100 million which missed the analyst consensus estimate of $24.133 million by 95.44 percent.</p>


ASTS

AST SpaceMobile Q3 2024 GAAP EPS $(1.10) Misses $(0.20) Estimate, Sales $1.100M Miss $24.133M Estimate

<p>Surf Air Mobility Inc. Common Stock (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SRFM#NYSE">SRFM</a>) reported quarterly losses of $(0.94) per share which beat the analyst consensus estimate of $(2.10) by 55.24 percent.  The company reported quarterly sales of $28.386 million which beat the analyst consensus estimate of $26.305 million by 7.91 percent.  This is a 29.22 percent increase over sales of $21.967 million the same period last year.</p>


SRFM

Surf Air Mobility Inc. Common Stock Q3 2024 GAAP EPS $(0.94) Beats $(2.10) Estimate, Sales $28.386M Beat $26.305M Estimate

<p>Emeren Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOL#NYSE">SOL</a>) lowers FY2024 sales outlook from $150.00 million-160.00 million to $97.00 million-102.00 million.</p>


Guidance

Emeren Group Lowers FY2024 Sales Guidance from $150.00M-$160.00M to $97.00M-$102.00M  VS Est. $151.34M

<p>Precision Optics Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POCI#NASDAQ">POCI</a>) reported quarterly losses of $(0.21) per share. This is a 162.5 percent decrease over losses of $(0.08) per share from the same period last year.  The company reported $4.20 million in sales this quarter. This is a 2.88 percent decrease over sales of $4.32 million the same period last year.</p>


POCI

Precision Optics Corp Q1 EPS $(0.21) Down From $(0.08) YoY, Sales $4.20M Down From $4.32M YoY

Contracts

AXON

Axon To Supply Royal Canadian Mounted Police (RCMP) With Body-Worn Cameras

<p>Ryvyl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RVYL#NASDAQ">RVYL</a>) reported quarterly losses of $(0.76) per share which missed the analyst consensus estimate of $(0.27) by 181.48 percent. This is a 26.67 percent decrease over losses of $(0.60) per share from the same period last year.  The company reported quarterly sales of $12.61 million which missed the analyst consensus estimate of $13.92 million by 9.44 percent.  This is a 27.88 percent decrease over sales of $17.48 million the same period last year.</p>


RVYL

Ryvyl Q3 EPS $(0.76) Misses $(0.27) Estimate, Sales $12.61M Miss $13.92M Estimate

<p>Hyliion Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HYLN#NYSE">HYLN</a>) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.07) by 14.29 percent.</p>


HYLN

Hyliion Holdings Q3 2024 GAAP EPS $(0.06) Beats $(0.07) Estimate

Guardion Health Sciences reports Q1 results

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p><strong>Guardion Health Sciences</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/ghsi-stock-quote/"><strong>GHSI</strong></a></span>) just reported results for the first quarter of 2024.</p><ul><li>Guardion Health Sciences reported earnings per share of -$3.71. This was below the analyst estimate for EPS of -88 cents.</li><li>The company reported revenue of $3.00 million.</li><li>This was 3.86% worse than the analyst estimate for revenue of $3.12 million.</li></ul><div><p>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	<p>The post <a href="https://investorplace.com/earning-results/2024/05/ghsi-stock-earnings-guardion-health-sciences-for-q1-of-2024/">GHSI Stock Earnings: Guardion Health Sciences Misses EPS, Misses Revenue for Q1 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

GHSI Stock Earnings: Guardion Health Sciences Misses EPS, Misses Revenue for Q1 2024

Tandem Diabetes Care, Guardion Health, GT Biopharma among healthcare movers

Guardion Health Sciences (GHSI) has issued an announcement. Guardion Health Sciences, Inc. has mutually agreed with Craig Sheehan, its Chief Commer...

Guardion Health Sciences CCO Sheehan Exits with Compensation

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p><strong>Guardion Health Sciences</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/ghsi-stock-quote/"><strong>GHSI</strong></a></span>) just reported results for the second quarter of 2024.</p><ul><li>Guardion Health Sciences reported earnings per share of -$1.64. This was below the analyst estimate for EPS of -66 cents.</li><li>The company reported revenue of $72,918.</li><li>This was 97.73% worse than the analyst estimate for revenue of $3.21 million.</li></ul><div><p>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><p>The post <a href="https://investorplace.com/earning-results/2024/08/ghsi-stock-earnings-guardion-health-sciences-for-q2-of-2024/">GHSI Stock Earnings: Guardion Health Sciences Misses EPS, Misses Revenue for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

GHSI Stock Earnings: Guardion Health Sciences Misses EPS, Misses Revenue for Q2 2024

Guardion Health Sciences reports Q2 results

Guardion Health Sciences declares $5.00 dividend

Guardion Health Sciences ( ($GHSI) ) has shared an announcement. Guardion Health Sciences, Inc. has announced the departure of its President and CE...

Guardion Health Sciences CEO Jan Hall Set to Depart

Guardion Health Sciences announces adoption of plan of dissolution and liquidation

Guardion Health Sciences ( ($GHSI) ) has issued an announcement. Guardion Health Sciences, Inc. has initiated a significant corporate shakeup, anno...

Guardion Health Sciences Announces Delisting and New Interim CEO

AONC

BDRX

GTBP

LSDI

MYMD

SABS

TNDM

XYLO

Small Cap

Opinion

Press Releases

Thinking about buying stock in Guardion Health Sciences, Minim, Revelation Biosciences, Nyxoah, or Pixelworks?

Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2023

Guardion Health Sciences Announces

Guardion Health Sciences Announces its Largest Stockholder Has Voted in Favor of Proposals to Sell the Viactiv Business and the Liquidation Plan at the Company's Special Meeting of Stockholders to be held on May 23, 2024

Guardion Health Sciences Announces Approval by Stockholders of Proposed Sale of Viactiv Business

Guardion Health Sciences Announces Completion of Sale of its Viactiv® Brand and Business to Doctor's Best Inc. and Stockholder Approval of Plan of Liquidation and Dissolution

Guardion Health Sciences Announces Financial Results for the Three Months and Six Months Ended June 30, 2024

Guardion Health Sciences Declares Cash Dividend of $5.00 Per Share of Common Stock

Guardion Health Sciences Announces Adoption of Plan of Dissolution and Liquidation; Appointment of Interim President and CEO

Comments

Guardion Health Sciences

Guardion Health Sciences (GHSI) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga